ORPEA: Q3 revenue ahead consensus with FY guidance adjusted upwards. New acquisition in Germany to expand high-end nursing homes | BUY | EUR125
ORPEA - BUY | EUR125(+16%)Q3 revenue ahead consensus with FY guidance adjusted upwards. New acquisition in Germany to expand high-end nursing homes
Solid Q3 organic revenue growth
FY guidance upgraded but already acted by consensus
New acquisition in Germany to build up an offer in the premium nursing home segment in that geography
ORPEA is a dependency, physical and psychiatric care group based in France. Co. operates long-term and short-term care facilities, including medical care facilities, medical and social care facilities and residential facilities for the elderly. Co. provides short, medium and long-term global physical and mental dependency care. Co. also operates residential facilities for disabled people of any age, hotels, and hotel-related, as well as leisure accommodation facilities. Co. operates in France and abroad (Belgium, Italy, Spain and Switzerland) in three business segments: Long-term care facilities (nursing homes); Post-acute and Rehabilitation care facilities; and Psychiatric care facilities.
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.